Amneal Pharmaceuticals Inc Class A (AMRX)
Other Income/Expenses (Net)
-$202.06M
TTM · Period ending: · USD
AMRX Other Income/Expenses (Net)
Latest reported-$202.06Mperiod ending
Latest reported-$202.06Mperiod ending
AMRX Other Income/Expenses (Net) (-$39.24M → -$202.06M)
Annual Other Income/Expenses (Net)
High-resolution chart · PNG
AMRX other income/expenses (net) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -283,881,000 | |
| -304,339,000 | |
| -244,644,000 | |
| -153,199,000 | |
| -121,350,000 | |
| -126,935,000 | |
| 28,440,000 | |
| -183,049,000 | |
| -73,780,000 | |
| -70,060,000 | |
| -60,576,000 | |
| -39,244,000 |